ANTEPSIN

ANTEPSIN

Marketed by: Orion Oyj
Active ingredient: Sucralfatum
Other information: oral suspension - 200 mg/ml

Available in: Finland
Language: English
Source: Fimea

ALSUCRAL

ALSUCRAL

Marketed by: Orion Oyj
Active ingredient: Sucralfatum
Other information: chewable tablet - 1 g

Available in: Finland
Language: English
Source: Fimea

ALGICON

ALGICON

Marketed by: Schering Oy
Active ingredient: Magnesii alginas,Magnesii carbonas,Kalii hydrogenocarbonas,Aluminii hydroxidum-magnesii carbonas gel.
Other information: oral liquid

Available in: Finland
Language: English
Source: Fimea

ALGICON

ALGICON

Marketed by: Schering Oy
Active ingredient: Aluminii hydroxidum-magnesii carbonas gel.,Kalii hydrogenocarbonas,Magnesii alginas,Magnesii carbonas
Other information: chewable tablet

Available in: Finland
Language: English
Source: Fimea

AEROPAX

AEROPAX

Marketed by: Orion Pharma A/S
Active ingredient: Antifoam a
Other information: oral liquid - 10 mg/ml

Available in: Finland
Language: English
Source: Fimea

AEROPAX

AEROPAX

Marketed by: Orion Pharma A/S
Active ingredient: Antifoam a
Other information: chewable tablet - 40 mg

Available in: Finland
Language: English
Source: Fimea

ATROPIN

ATROPIN

Marketed by: Oy Leiras Finland Ab
Active ingredient: Atropini sulfas
Other information: solution for injection - 1 mg/ml

Available in: Finland
Language: English
Source: Fimea

ATROPIN

ATROPIN

Marketed by: Orion Oyj
Active ingredient: Atropini sulfas
Other information: injection - 1 mg/ml

Available in: Finland
Language: English
Source: Fimea

ANZEMET

ANZEMET

Marketed by: sanofi-Aventis Oy
Active ingredient: Dolasetroni mesilas
Other information: film-coated tablet - 50 mg

Available in: Finland
Language: English
Source: Fimea

ANZEMET

ANZEMET

Marketed by: sanofi-Aventis Oy
Active ingredient: Dolasetroni mesilas
Other information: film-coated tablet - 200 mg

Available in: Finland
Language: English
Source: Fimea

ANZEMET

ANZEMET

Marketed by: sanofi-Aventis Oy
Active ingredient: Dolasetroni mesilas
Other information: solution for injection - 20 mg/ml

Available in: Finland
Language: English
Source: Fimea

ADURSAL

ADURSAL

Marketed by: Oy Leiras Finland Ab
Active ingredient: Acidum ursodeoxycholicum
Other information: film-coated tablet - 150 mg

Available in: Finland
Language: English
Source: Fimea

ARGININ GLUTAMIQUE

ARGININ GLUTAMIQUE

Marketed by: SOBIO
Active ingredient: Arginini monoglutamas
Other information: solution - 250 mg/ml

Available in: Finland
Language: English
Source: Fimea

AGAROL

AGAROL

Marketed by: H.Lundbeck A/S
Active ingredient: Phenolphthaleinum,Paraffinum liquidum
Other information: oral liquid

Available in: Finland
Language: English
Source: Fimea

AGIOPIC

AGIOPIC

Marketed by: Madaus GmbH
Active ingredient: Natrii picosulfas
Other information: lozenge - 5 mg

Available in: Finland
Language: English
Source: Fimea

ASACOL

ASACOL

Marketed by: Tillotts Pharma AB
Active ingredient: Mesalazinum
Other information: gastro-resistant tablet - 400 mg

Available in: Finland
Language: English
Source: Fimea

ASACOL

ASACOL

Marketed by: Tillotts Pharma AB
Active ingredient: Mesalazinum
Other information: suppository - 500 mg

Available in: Finland
Language: English
Source: Fimea

ASACOL

ASACOL

Marketed by: Tillotts Pharma AB
Active ingredient: Mesalazinum
Other information: enema - 1 g

Available in: Finland
Language: English
Source: Fimea

ASACOL

ASACOL

Marketed by: Tillotts Pharma AB
Active ingredient: Mesalazinum
Other information: gastro-resistant tablet - 800 mg

Available in: Finland
Language: English
Source: Fimea

ASACOL

ASACOL

Marketed by: RÖHM
Active ingredient: Mesalazinum
Other information: prolonged-release tablet - 400 mg

Available in: Finland
Language: English
Source: Fimea

ACTRAPID INNOLET

ACTRAPID INNOLET

Marketed by: Novo Nordisk A/S
Active ingredient: Insulinum humanum
Other information: solution for injection - 100 IU/ml

Available in: Finland
Language: English
Source: Fimea

ACTRAPID FLEXPEN

ACTRAPID FLEXPEN

Marketed by: Novo Nordisk A/S
Active ingredient: Insulinum humanum
Other information: solution for injection - 100 IU/ml

Available in: Finland
Language: English
Source: Fimea

INSULIN ACTRAPID HUMAN

INSULIN ACTRAPID HUMAN

Marketed by: Novo Nordisk A/S
Active ingredient: Insulinum monocomponent. (humanum)
Other information: solution for injection - 100 IU/ml

Available in: Finland
Language: English
Source: Fimea

ALENTIN

ALENTIN

Marketed by: REMEDA
Active ingredient: Carbutamidum
Other information: tablet - 500 mg

Available in: Finland
Language: English
Source: Fimea

APAMID

APAMID

Marketed by: Weifa AS
Active ingredient: Glipizidum
Other information: tablet - 2.5 mg

Available in: Finland
Language: English
Source: Fimea

APAMID

APAMID

Marketed by: Weifa AS
Active ingredient: Glipizidum
Other information: tablet - 5 mg

Available in: Finland
Language: English
Source: Fimea

AMARYL

AMARYL

Marketed by: sanofi-Aventis Oy
Active ingredient: Glimepiridum
Other information: tablet - 1 mg

Available in: Finland
Language: English
Source: Fimea

AMARYL

AMARYL

Marketed by: sanofi-Aventis Oy
Active ingredient: Glimepiridum
Other information: tablet - 2 mg

Available in: Finland
Language: English
Source: Fimea

AMARYL

AMARYL

Marketed by: sanofi-Aventis Oy
Active ingredient: Glimepiridum
Other information: tablet - 3 mg

Available in: Finland
Language: English
Source: Fimea

AMARYL

AMARYL

Marketed by: sanofi-Aventis Oy
Active ingredient: Glimepiridum
Other information: tablet - 4 mg

Available in: Finland
Language: English
Source: Fimea